Trial intelligence / Profile preview

Pilot trial of tranexamic acid in hip or knee joint replacement

ACTRN12613000323729Phase 4Completed

Sponsor
Royal Adelaide Hospital
Start
May 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Bleeding comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Feasibility of extending methodology to a large pragmatic multicenter trial and Proportion of patients receiving allogeneic blood transfusion. Started May 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

Bleeding

Beyond the preview

Go deeper on ACTRN12613000323729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000323729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call